Benjamin Jacob
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Benjamin Jacob has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
Patrick Redmond
Royal College Of Surgeons In Ireland (RCSI), Dublin, Ireland
20 shared publications- Patrick Redmond
Department of General Practice RCSI University of Medicine and Health Sciences Dublin Ireland
16 shared publications Heather Burns
National Cancer Control Programme, Health Service Executive, Dublin, Ireland
9 shared publications- Seamus Cotter
Irish Lung Cancer Community, Dublin
7 shared publications Alan Smith
HSE, National Screening Service, Dublin, Ireland
6 shared publications- Conor F. Murphy
Department of General Practice, Royal College of Surgeons in Ireland (RCSI), Dublin
6 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Wiley in Journal of General and Family Medicine
- Vol. 27 (6)
Mapping Irish Primary Care Research Across the Cancer Continuum: A Scoping Review and Bibliometric Analysis
Background: The scope of primary care cancer research on the island of Ireland has not been clearly mapped, despite primary care's pivotal role across the cancer care continuum. Methods: We conducted a systematic search of studies from the Republic of Ireland (RoI) and Northern Ireland (NI) up until October 2022 and summarized the literature using bibliometric analysis and narrative synthesis. From 3911 screened abstracts, 100 eligible outputs were identified: 60 journal articles, 38 conference abstracts, and 2 doctoral theses. Most papers (92%) were published after 2000. Results: Research output from NI and the RoI was proportional to population size; only one cross‐border study was identified. Study designs were predominantly comparative observational (51%), with fewer non‐comparative observational (23%), qualitative (23%), and experimental studies (3%). The most frequently studied cancers were cervical, breast, prostate, lung, and colorectal. Conclusion: This review provides a foundation for strategically directing future primary care cancer research in Ireland.
- 4 November 2026
- Published by Wiley in Journal of General and Family Medicine
- Vol. 27 (6)
Open AccessMapping Irish Primary Care Research Across the Cancer Continuum: A Scoping Review and Bibliometric Analysis
Background: The scope of primary care cancer research on the island of Ireland has not been clearly mapped, despite primary care's pivotal role across the cancer care continuum. Methods: We conducted a systematic search of studies from the Republic of Ireland (RoI) and Northern Ireland (NI) up until October 2022 and summarized the literature using bibliometric analysis and narrative synthesis. From 3911 screened abstracts, 100 eligible outputs were identified: 60 journal articles, 38 conference abstracts, and 2 doctoral theses. Most papers (92%) were published after 2000. Results: Research output from NI and the RoI was proportional to population size; only one cross‐border study was identified. Study designs were predominantly comparative observational (51%), with fewer non‐comparative observational (23%), qualitative (23%), and experimental studies (3%). The most frequently studied cancers were cervical, breast, prostate, lung, and colorectal. Conclusion: This review provides a foundation for strategically directing future primary care cancer research in Ireland.
- Open Access
Prevalence and Management of Chronic Kidney Disease in Irish Primary Care Network
Background: Chronic kidney disease (CKD) imposes a substantial burden on health systems and society. Although early detection and guideline-recommended management can improve outcomes, opportunities remain to enhance management in primary care. Aim: To evaluate CKD prevalence, guideline-directed medical therapy (GDMT), and monitoring in Irish primary care. Design and Setting: Retrospective cohort study using community-based electronic health records (EHR) from the CRADLE database, across 66 Irish practices. Methods: Active adults aged ≥20 years on 30 July 2025 were included. CKD prevalence was determined using estimated glomerular filtration rate (eGFR) and/or urine albumin-to-creatinine ratio (uACR). Descriptive analyses of epidemiology, prescribing, and monitoring were conducted. Results: Of 468,534 adults, 19,382 met the criteria of laboratory-confirmed CKD: age- and sex-standardised prevalence was 5.36%. 74.0% of laboratory-confirmed CKD patients have ≥1 cardiometabolic comorbidities. Within 12 months of laboratory-confirmed CKD, monitoring increased over time, with 66.0% of patients receiving follow-up eGFR test and 15.1% receiving uACR test, falling to 6.6% among patients without type 2 diabetes (T2DM). Among GDMT-eligible CKD patients, 64.0% received any renin-angiotensin-aldosterone inhibitors (RAASi) and 30.9% received any sodium-glucose cotransporter 2 inhibitors (SGLT2i) after they met their prescription eligibility for CKD, but SGLT2i use dropped to 9.4% among those without T2DM or heart failure. Conclusion: CKD and cardiometabolic comorbidities impose a substantial burden in Irish primary care. Despite improved kidney function testing, albuminuria testing remained low, particularly in non-diabetic patients, and GDMT use was suboptimal. Improving albuminuria testing and timely GDMT offers important opportunities to improve CKD outcomes in Irish primary care.
Open AccessPrevalence and Management of Chronic Kidney Disease in Irish Primary Care Network
Background: Chronic kidney disease (CKD) imposes a substantial burden on health systems and society. Although early detection and guideline-recommended management can improve outcomes, opportunities remain to enhance management in primary care. Aim: To evaluate CKD prevalence, guideline-directed medical therapy (GDMT), and monitoring in Irish primary care. Design and Setting: Retrospective cohort study using community-based electronic health records (EHR) from the CRADLE database, across 66 Irish practices. Methods: Active adults aged ≥20 years on 30 July 2025 were included. CKD prevalence was determined using estimated glomerular filtration rate (eGFR) and/or urine albumin-to-creatinine ratio (uACR). Descriptive analyses of epidemiology, prescribing, and monitoring were conducted. Results: Of 468,534 adults, 19,382 met the criteria of laboratory-confirmed CKD: age- and sex-standardised prevalence was 5.36%. 74.0% of laboratory-confirmed CKD patients have ≥1 cardiometabolic comorbidities. Within 12 months of laboratory-confirmed CKD, monitoring increased over time, with 66.0% of patients receiving follow-up eGFR test and 15.1% receiving uACR test, falling to 6.6% among patients without type 2 diabetes (T2DM). Among GDMT-eligible CKD patients, 64.0% received any renin-angiotensin-aldosterone inhibitors (RAASi) and 30.9% received any sodium-glucose cotransporter 2 inhibitors (SGLT2i) after they met their prescription eligibility for CKD, but SGLT2i use dropped to 9.4% among those without T2DM or heart failure. Conclusion: CKD and cardiometabolic comorbidities impose a substantial burden in Irish primary care. Despite improved kidney function testing, albuminuria testing remained low, particularly in non-diabetic patients, and GDMT use was suboptimal. Improving albuminuria testing and timely GDMT offers important opportunities to improve CKD outcomes in Irish primary care.
- Open Access
Missed Opportunities for Chronic Kidney Disease Recognition in Irish Primary Care: A Nationwide Electronic Health Record Study
Objectives: To examine chronic kidney disease (CKD) diagnostic coding in Irish primary care using electronic health records (EHRs). Methods: This retrospective cohort study used EHR data from 592,888 active patients across 66 Irish primary care practices. Adults aged ≥20 years meeting laboratory-based CKD criteria were identified. CKD coding was defined by the presence of an ICD-10 or ICPC-2 diagnosis code. Coding rates were evaluated overall and by CKD stages, comorbidities, and practices. Results: Among 19,382 adults with laboratory-confirmed CKD (median age 76 years; 55.7% female), 14.6% had a documented CKD diagnosis code. Coding increased with disease severity, from 4.8% in stages 1-2 to 19.6% in stages 3-5, and varied by comorbidity burden, with only 10.1% of patients without major cardiometabolic comorbidities coded. Substantial practice-level variation was observed, with over half of practices (34/61) recording coding rates below 10%, while four exceeded 40%. Most patients (85.4%) remained uncoded throughout follow-up. Conclusions: This first nationwide study of CKD coding in Irish primary care network demonstrates substantial under-coding despite laboratory evidence, with marked variation between practices. Improving coding consistency and completeness may enhance CKD recognition, support earlier intervention, and improve patient outcomes.
Open AccessMissed Opportunities for Chronic Kidney Disease Recognition in Irish Primary Care: A Nationwide Electronic Health Record Study
Objectives: To examine chronic kidney disease (CKD) diagnostic coding in Irish primary care using electronic health records (EHRs). Methods: This retrospective cohort study used EHR data from 592,888 active patients across 66 Irish primary care practices. Adults aged ≥20 years meeting laboratory-based CKD criteria were identified. CKD coding was defined by the presence of an ICD-10 or ICPC-2 diagnosis code. Coding rates were evaluated overall and by CKD stages, comorbidities, and practices. Results: Among 19,382 adults with laboratory-confirmed CKD (median age 76 years; 55.7% female), 14.6% had a documented CKD diagnosis code. Coding increased with disease severity, from 4.8% in stages 1-2 to 19.6% in stages 3-5, and varied by comorbidity burden, with only 10.1% of patients without major cardiometabolic comorbidities coded. Substantial practice-level variation was observed, with over half of practices (34/61) recording coding rates below 10%, while four exceeded 40%. Most patients (85.4%) remained uncoded throughout follow-up. Conclusions: This first nationwide study of CKD coding in Irish primary care network demonstrates substantial under-coding despite laboratory evidence, with marked variation between practices. Improving coding consistency and completeness may enhance CKD recognition, support earlier intervention, and improve patient outcomes.
- Open Access
- 23 October 2026
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 9, 107
Risk of Cancer following Non-Specific Symptoms in Primary Care: Protocol for a Programme of EHR-Based Research in Primary Care
Background Non-specific symptoms of cancer (NSSoC), such as thrombocytosis, unexplained weight loss, and persistent fatigue, are frequently the earliest presenting feature of malignancy in primary care. Approximately 22% of cancers present with NSSoC alone, yet these symptoms have low individual positive predictive values and do not meet criteria for existing site-specific referral pathways. International evidence demonstrates that structured NSSoC pathways detect cancer in 7–20% of referrals. Ireland currently lacks both a national NSSoC referral pathway and the population-level epidemiological data required to inform one. Aim To conduct a programme of linked observational studies examining the prevalence, cancer conversion rates, and diagnostic intervals associated with NSSoC in Irish general practice. The initial pre-specified analysis focuses on thrombocytosis, using structured laboratory data to establish the analytical framework before extension to symptom-based NSSoC. Methods This protocol describes a retrospective cohort study using the CRADLE database (66 general practices; ~521,000 patients; 2.16 million person-years). Four integrated components will: (i) estimate NSSoC consultation-level burden, person-level annual incidence, and test positivity rates; (ii) characterise pre-diagnostic symptom trajectories via matched case-control diagnostic window analyses; (iii) estimate 6- and 12-month absolute cancer risk and cumulative incidence, accounting for competing mortality; and (iv) model adjusted cancer risk. Cancer outcomes are ascertained from GP-coded diagnoses; the absence of National Cancer Registry linkage is a primary limitation, and conversion rate estimates should be regarded as provisional. Implications This study will provide the first Irish primary care estimates of NSSoC burden and short-term cancer risk. Findings will generate candidate risk estimates to inform microsimulation modelling of a potential NSSoC pathway, contributing to the goals of the NCCP Early Diagnosis Plan 2022–2027. Definitive referral thresholds will require validation through cancer registry linkage and prospective evaluation.
- 23 October 2026
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 9, 107
Open AccessRisk of Cancer following Non-Specific Symptoms in Primary Care: Protocol for a Programme of EHR-Based Research in Primary Care
Background Non-specific symptoms of cancer (NSSoC), such as thrombocytosis, unexplained weight loss, and persistent fatigue, are frequently the earliest presenting feature of malignancy in primary care. Approximately 22% of cancers present with NSSoC alone, yet these symptoms have low individual positive predictive values and do not meet criteria for existing site-specific referral pathways. International evidence demonstrates that structured NSSoC pathways detect cancer in 7–20% of referrals. Ireland currently lacks both a national NSSoC referral pathway and the population-level epidemiological data required to inform one. Aim To conduct a programme of linked observational studies examining the prevalence, cancer conversion rates, and diagnostic intervals associated with NSSoC in Irish general practice. The initial pre-specified analysis focuses on thrombocytosis, using structured laboratory data to establish the analytical framework before extension to symptom-based NSSoC. Methods This protocol describes a retrospective cohort study using the CRADLE database (66 general practices; ~521,000 patients; 2.16 million person-years). Four integrated components will: (i) estimate NSSoC consultation-level burden, person-level annual incidence, and test positivity rates; (ii) characterise pre-diagnostic symptom trajectories via matched case-control diagnostic window analyses; (iii) estimate 6- and 12-month absolute cancer risk and cumulative incidence, accounting for competing mortality; and (iv) model adjusted cancer risk. Cancer outcomes are ascertained from GP-coded diagnoses; the absence of National Cancer Registry linkage is a primary limitation, and conversion rate estimates should be regarded as provisional. Implications This study will provide the first Irish primary care estimates of NSSoC burden and short-term cancer risk. Findings will generate candidate risk estimates to inform microsimulation modelling of a potential NSSoC pathway, contributing to the goals of the NCCP Early Diagnosis Plan 2022–2027. Definitive referral thresholds will require validation through cancer registry linkage and prospective evaluation.
- Open Access
- 11 October 2026
- Published by Wiley in British Journal of Clinical Pharmacology
Practice‐level variation in potentially inappropriate prescribing in middle‐aged adults: A repeated cross‐sectional study in South London general practice
Aim: To quantify between‐practice variation in potentially inappropriate prescribing (PIP) among middle‐aged adults (45–64 years) in UK general practice, and to identify patient‐ and practice‐level characteristics associated with PIP. Methods: Repeated cross‐sectional study using linked data from the Lambeth DataNet and Quality Outcomes Framework across 41 GP practices in South London (2014–2019). The study included patients aged 45–64 years prescribed ≥1 medicines in each year from 2014 to 2019 ( n = 46 633–52 582). PIP was identified using the 22 PROMPT (PRescribing Optimally in Middle‐aged People's Treatments) criteria. Multilevel negative binomial regression estimated associations with patient‐ and practice‐level characteristics, expressed as rate ratios (RR) with 95% confidence intervals. Results: PIP prevalence was 18%–20%, stable across the study period. Practice‐level prevalence ranged from 14% to 24%. The SCV was 1.72 (low) and the ICC was 0.08, with approximately 8% of variance attributable to practice‐level differences. Polypharmacy was the strongest predictor (adjusted RR 4.04, 95% CI 3.96–4.11), followed by multimorbidity (RR 2.44, 95% CI 2.40–2.50). Black/African/Caribbean/Black British ethnicity was associated with lower PIP (RR 0.77, 95% CI 0.75–0.78). Practice‐based pharmacist presence and teaching practice status were associated with modestly lower PIP, while APMS contract type was associated with higher PIP (RR 1.20, 95% CI 1.10–1.32). Conclusion: Most variation occurred at the patient level, but practice organizational characteristics were also associated with PIP and warrant further investigation in an age group for which direct medicines‐optimization evidence remains limited.
- 11 October 2026
- Published by Wiley in British Journal of Clinical Pharmacology
Open AccessPractice‐level variation in potentially inappropriate prescribing in middle‐aged adults: A repeated cross‐sectional study in South London general practice
Aim: To quantify between‐practice variation in potentially inappropriate prescribing (PIP) among middle‐aged adults (45–64 years) in UK general practice, and to identify patient‐ and practice‐level characteristics associated with PIP. Methods: Repeated cross‐sectional study using linked data from the Lambeth DataNet and Quality Outcomes Framework across 41 GP practices in South London (2014–2019). The study included patients aged 45–64 years prescribed ≥1 medicines in each year from 2014 to 2019 ( n = 46 633–52 582). PIP was identified using the 22 PROMPT (PRescribing Optimally in Middle‐aged People's Treatments) criteria. Multilevel negative binomial regression estimated associations with patient‐ and practice‐level characteristics, expressed as rate ratios (RR) with 95% confidence intervals. Results: PIP prevalence was 18%–20%, stable across the study period. Practice‐level prevalence ranged from 14% to 24%. The SCV was 1.72 (low) and the ICC was 0.08, with approximately 8% of variance attributable to practice‐level differences. Polypharmacy was the strongest predictor (adjusted RR 4.04, 95% CI 3.96–4.11), followed by multimorbidity (RR 2.44, 95% CI 2.40–2.50). Black/African/Caribbean/Black British ethnicity was associated with lower PIP (RR 0.77, 95% CI 0.75–0.78). Practice‐based pharmacist presence and teaching practice status were associated with modestly lower PIP, while APMS contract type was associated with higher PIP (RR 1.20, 95% CI 1.10–1.32). Conclusion: Most variation occurred at the patient level, but practice organizational characteristics were also associated with PIP and warrant further investigation in an age group for which direct medicines‐optimization evidence remains limited.
- Open Access
- 21 July 2026
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 9, 11
AI Digital Scribe Template Enhancement for Non-Specific Symptom Documentation in Irish General Practice: A Mixed-Methods Feasibility Protocol
Background Non-specific symptoms (NSS) such as unexplained fatigue, weight loss, or abdominal discomfort are common in general practice and may herald serious disease, including cancer. These symptoms are less consistently recorded than “alarm” symptoms, partly because time-pressured consultations limit comprehensive documentation. AI-enabled digital scribes are increasingly used in routine consultations and can be configured with templates to surface specified symptom groups, but their acceptability and practical value for NSS documentation in primary care are unknown. Aim To assess the acceptability and feasibility of an AI digital scribe template, enhanced for NSS documentation in Irish general practice, and to describe patterns of NSS documentation in template-generated consultation notes. Design and Setting Mixed-methods feasibility study in general practices within the ARQ Practice-Based Research Network in Ireland, all of which routinely use the Heidi™ AI medical scribe. Method In Phase 1 we will iteratively develop an NSS-focused template (covering nine target symptoms) and test it on publicly available primary care consultation data. In Phase 2, five purposively sampled GPs (n = 5) will deploy the template during routine consultations over four weeks. In Phase 3, all GPs in the network using Heidi™ (n = 30) will be invited to complete an online acceptability survey, with semi-structured interviews for pilot participants (n = 5). In Phase 4, a pseudonymised chart review of clinical notes will describe template utilisation, GP editing behaviour, and NSS documentation prevalence. Quantitative data will be analysed descriptively; qualitative data will be analysed using the Framework Method and integrated using convergence coding matrices. Expected Outcomes Primary feasibility outcomes are: recruitment and retention of GPs; template use during routine consultations; template acceptability; and completeness of routine data extraction. Findings will inform refinement of the NSS template and the design of subsequent evaluative studies examining clinical impact. Study materials will be available via the Open Science Framework.
- 21 July 2026
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 9, 11
Open AccessAI Digital Scribe Template Enhancement for Non-Specific Symptom Documentation in Irish General Practice: A Mixed-Methods Feasibility Protocol
Background Non-specific symptoms (NSS) such as unexplained fatigue, weight loss, or abdominal discomfort are common in general practice and may herald serious disease, including cancer. These symptoms are less consistently recorded than “alarm” symptoms, partly because time-pressured consultations limit comprehensive documentation. AI-enabled digital scribes are increasingly used in routine consultations and can be configured with templates to surface specified symptom groups, but their acceptability and practical value for NSS documentation in primary care are unknown. Aim To assess the acceptability and feasibility of an AI digital scribe template, enhanced for NSS documentation in Irish general practice, and to describe patterns of NSS documentation in template-generated consultation notes. Design and Setting Mixed-methods feasibility study in general practices within the ARQ Practice-Based Research Network in Ireland, all of which routinely use the Heidi™ AI medical scribe. Method In Phase 1 we will iteratively develop an NSS-focused template (covering nine target symptoms) and test it on publicly available primary care consultation data. In Phase 2, five purposively sampled GPs (n = 5) will deploy the template during routine consultations over four weeks. In Phase 3, all GPs in the network using Heidi™ (n = 30) will be invited to complete an online acceptability survey, with semi-structured interviews for pilot participants (n = 5). In Phase 4, a pseudonymised chart review of clinical notes will describe template utilisation, GP editing behaviour, and NSS documentation prevalence. Quantitative data will be analysed descriptively; qualitative data will be analysed using the Framework Method and integrated using convergence coding matrices. Expected Outcomes Primary feasibility outcomes are: recruitment and retention of GPs; template use during routine consultations; template acceptability; and completeness of routine data extraction. Findings will inform refinement of the NSS template and the design of subsequent evaluative studies examining clinical impact. Study materials will be available via the Open Science Framework.
- Open Access
- 11 July 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Estimating stage-specific lung cancer costs for economic evaluation of LDCT screening in Ireland: a patient-level microsimulation
Lung cancer imposes a significant clinical and economic burden in Ireland, with low five-year survival rates and no national low-dose computed tomography (
- 11 July 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Open AccessEstimating stage-specific lung cancer costs for economic evaluation of LDCT screening in Ireland: a patient-level microsimulation
Lung cancer imposes a significant clinical and economic burden in Ireland, with low five-year survival rates and no national low-dose computed tomography (
- Open Access
- 19 May 2026
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 9, 54
Early detection of symptomatic cancer in primary care in Ireland: a research prioritisation exercise
Background Early detection of symptomatic cancer in primary care is critical to improving outcomes, yet research in this area remains underfunded relative to potential impact. Involving those most affected in research prioritisation ensures focus on the most significant questions. This study aimed to identify and rank the most important research priorities for early detection of symptomatic cancer in Irish primary care, as determined by patients, carers, and clinicians. Methods We conducted a research prioritisation exercise adapted from the James Lind Alliance (JLA) framework, reported according to REPRISE guidelines. The study comprised four stages: (1) an in-person stakeholder workshop gathering research uncertainties (n = 16); (2) an online survey collecting further uncertainties from a broader population (n = 135); (3) processing, evidence checking, and interim prioritisation of uncertainties; and (4) a final consensus workshop to agree and rank the Top 10 priorities (n = 8). Submissions were disaggregated into 232 statements, of which 194 were in scope; these were synthesised into 30 summary research questions. Evidence checking confirmed none were fully addressed in the literature. Interim prioritisation produced a shortlist of 20 questions, discussed and ranked at the final workshop. Results The Top 10 priorities span five thematic domains: timely access to diagnostics and referral pathways (priorities 1, 3, 4); communication and patient–clinician interaction (priority 2); clinical complexity and decision support (priorities 5, 7); technology and innovation (priorities 6, 10); and equity-sensitive pathways and safety-netting (priorities 8, 9). The highest-ranked priority was ensuring timely access to GP-requested diagnostics for patients presenting possible cancer symptoms. The full ranked list of 20 priorities and all 30 questions are provided. Conclusions These co-produced priorities establish a stakeholder-informed roadmap for early cancer detection research in Irish primary care, aligned with the NCCP Early Diagnosis of Symptomatic Cancer Plan, and provide a framework for researchers, funders, and policymakers to prioritise investment.
- 19 May 2026
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 9, 54
Open AccessEarly detection of symptomatic cancer in primary care in Ireland: a research prioritisation exercise
Background Early detection of symptomatic cancer in primary care is critical to improving outcomes, yet research in this area remains underfunded relative to potential impact. Involving those most affected in research prioritisation ensures focus on the most significant questions. This study aimed to identify and rank the most important research priorities for early detection of symptomatic cancer in Irish primary care, as determined by patients, carers, and clinicians. Methods We conducted a research prioritisation exercise adapted from the James Lind Alliance (JLA) framework, reported according to REPRISE guidelines. The study comprised four stages: (1) an in-person stakeholder workshop gathering research uncertainties (n = 16); (2) an online survey collecting further uncertainties from a broader population (n = 135); (3) processing, evidence checking, and interim prioritisation of uncertainties; and (4) a final consensus workshop to agree and rank the Top 10 priorities (n = 8). Submissions were disaggregated into 232 statements, of which 194 were in scope; these were synthesised into 30 summary research questions. Evidence checking confirmed none were fully addressed in the literature. Interim prioritisation produced a shortlist of 20 questions, discussed and ranked at the final workshop. Results The Top 10 priorities span five thematic domains: timely access to diagnostics and referral pathways (priorities 1, 3, 4); communication and patient–clinician interaction (priority 2); clinical complexity and decision support (priorities 5, 7); technology and innovation (priorities 6, 10); and equity-sensitive pathways and safety-netting (priorities 8, 9). The highest-ranked priority was ensuring timely access to GP-requested diagnostics for patients presenting possible cancer symptoms. The full ranked list of 20 priorities and all 30 questions are provided. Conclusions These co-produced priorities establish a stakeholder-informed roadmap for early cancer detection research in Irish primary care, aligned with the NCCP Early Diagnosis of Symptomatic Cancer Plan, and provide a framework for researchers, funders, and policymakers to prioritise investment.
- Open Access
- 5 May 2026
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 8, 3
Protocol of a Scoping Review on the Use of Transactional Data for Early Diagnosis (TRADED-ScR)
Background People experiencing homelessness face profound sexual health inequities, driven by overlapping structural vulnerabilities including housing instability, stigma, limited healthcare access, and social exclusion, as well as the complex lived realities associated with homelessness. Interventions designed to improve sexual health outcomes within this population are diverse, ranging from peer-led education to nurse-led clinical models and structural supports such as housing. However, the effectiveness of these interventions depends not only on their content but also on the contexts in which they are delivered and the circumstances of the populations they serve. A realist review seeks to understand how and why interventions work, for whom, and under what conditions by identifying context–mechanism–outcome configurations (CMOCs) that explain how outcomes are generated. Methods This review will follow Pawson’s six-step realist synthesis methodology. An initial programme theory has been developed through preliminary literature searches and will be refined iteratively as new evidence is gathered. Published and grey literature will be systematically searched and selected for their relevance to developing and testing CMOCs. Data extraction will focus on identifying key information which can contribute to understanding contextual factors, mechanisms, and outcomes across intervention types. The synthesis will develop, refine, and test theories that explain how sexual health interventions produce change in varied contexts. Patient and public involvement contributors will be consulted throughout the review to validate findings and support interpretation. Conclusion This review will generate transferable insights into how sexual health interventions for people experiencing homelessness work across different contexts. By identifying mechanisms that generate outcomes, and the conditions that shape them, the findings will support more context-sensitive and effective policy, practice, and service design. The results will be disseminated through peer-reviewed publications, practitioner-facing summaries, and community-informed outputs.
- 5 May 2026
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 8, 3
Open AccessProtocol of a Scoping Review on the Use of Transactional Data for Early Diagnosis (TRADED-ScR)
Background People experiencing homelessness face profound sexual health inequities, driven by overlapping structural vulnerabilities including housing instability, stigma, limited healthcare access, and social exclusion, as well as the complex lived realities associated with homelessness. Interventions designed to improve sexual health outcomes within this population are diverse, ranging from peer-led education to nurse-led clinical models and structural supports such as housing. However, the effectiveness of these interventions depends not only on their content but also on the contexts in which they are delivered and the circumstances of the populations they serve. A realist review seeks to understand how and why interventions work, for whom, and under what conditions by identifying context–mechanism–outcome configurations (CMOCs) that explain how outcomes are generated. Methods This review will follow Pawson’s six-step realist synthesis methodology. An initial programme theory has been developed through preliminary literature searches and will be refined iteratively as new evidence is gathered. Published and grey literature will be systematically searched and selected for their relevance to developing and testing CMOCs. Data extraction will focus on identifying key information which can contribute to understanding contextual factors, mechanisms, and outcomes across intervention types. The synthesis will develop, refine, and test theories that explain how sexual health interventions produce change in varied contexts. Patient and public involvement contributors will be consulted throughout the review to validate findings and support interpretation. Conclusion This review will generate transferable insights into how sexual health interventions for people experiencing homelessness work across different contexts. By identifying mechanisms that generate outcomes, and the conditions that shape them, the findings will support more context-sensitive and effective policy, practice, and service design. The results will be disseminated through peer-reviewed publications, practitioner-facing summaries, and community-informed outputs.
- Open Access
- 4 May 2026
- Published by Springer Nature in PharmacoEconomics - Open
- Vol. 10 (4) , 707-720
Estimating Eligibility for Lung Cancer Screening in Ireland: A Dynamic Modelling Study of Smoking Trends
Lung cancer screening (LCS) with low-dose computed tomography (LDCT) reduces mortality. Ireland will likely adopt a national screening programme in the coming years, and evidence on the size of the eligible population is required to inform planning. The objective was to estimate the number and characteristics of individuals in Ireland eligible for LCS under different international criteria and to project future uptake. We combined population data from the 2022 Census and subsequent projections with smoking history from the 2017 Eurobarometer survey. Eligibility was assessed under four criteria: Irish pilot (55-74 years, ≥ 20 pack-years, quit < 15 years), US Preventive Services Task Force (USPSTF) 2013, USPSTF 2021, and NELSON. Projections to 2045 accounted for demographic change and smoking trends. Expected uptake was estimated using participation rates from SUMMIT, a large UK LCS implementation trial. In 2022, 245,105 individuals met the Irish pilot criteria, and 345,328 met USPSTF 2021. Eligibility remains broadly stable until the mid-2030s, then declines across all criteria. Relative differences between criteria persist over time, with USPSTF 2021 consistently identifying the largest group. Applying SUMMIT uptake rates, around 36,000 LDCT scans annually would be required at steady state. Approximately a quarter of a million people in Ireland would currently be eligible for LCS, rising to more than 340,000 under broader criteria. Numbers are expected to remain high for the next decade before gradually declining. These findings provide key evidence for service capacity planning and highlight the importance of flexible programme design to meet future demand.
- 4 May 2026
- Published by Springer Nature in PharmacoEconomics - Open
- Vol. 10 (4) , 707-720
Open AccessEstimating Eligibility for Lung Cancer Screening in Ireland: A Dynamic Modelling Study of Smoking Trends
Lung cancer screening (LCS) with low-dose computed tomography (LDCT) reduces mortality. Ireland will likely adopt a national screening programme in the coming years, and evidence on the size of the eligible population is required to inform planning. The objective was to estimate the number and characteristics of individuals in Ireland eligible for LCS under different international criteria and to project future uptake. We combined population data from the 2022 Census and subsequent projections with smoking history from the 2017 Eurobarometer survey. Eligibility was assessed under four criteria: Irish pilot (55-74 years, ≥ 20 pack-years, quit < 15 years), US Preventive Services Task Force (USPSTF) 2013, USPSTF 2021, and NELSON. Projections to 2045 accounted for demographic change and smoking trends. Expected uptake was estimated using participation rates from SUMMIT, a large UK LCS implementation trial. In 2022, 245,105 individuals met the Irish pilot criteria, and 345,328 met USPSTF 2021. Eligibility remains broadly stable until the mid-2030s, then declines across all criteria. Relative differences between criteria persist over time, with USPSTF 2021 consistently identifying the largest group. Applying SUMMIT uptake rates, around 36,000 LDCT scans annually would be required at steady state. Approximately a quarter of a million people in Ireland would currently be eligible for LCS, rising to more than 340,000 under broader criteria. Numbers are expected to remain high for the next decade before gradually declining. These findings provide key evidence for service capacity planning and highlight the importance of flexible programme design to meet future demand.